Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01868230 · ClinicalTrials.gov registry record · NA

Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women

A NA study of Diabetes, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
232
Enrollment target
1
Study location

NCT01868230 is a NA study of Diabetes that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 232 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01868230, a NA study of Diabetes, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
232 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified, individually tailored lifestyle intervention to reduce excess gestational weight gain (GWG), increase postpartum weight loss, and improve maternal metabolic status among overweight/obese Hispanic women.

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle Intervention

Study Locations (1)

Massachusetts

  • Baystate Medical Center - Springfield

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2014-06
Est. Completion 2020-07
Phase NA

What the Registry Record Tells You About NCT01868230

The ClinicalTrials.gov registry entry for NCT01868230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Intervention is the first listed.

NCT01868230 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01868230 about?

NCT01868230 is a clinical study titled "Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women". The overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified, individually tailored lifestyle intervention to reduce excess gestational weight gain (GWG), increase postpartum weight loss, and improve maternal metabolic status among overweig...

What is the current status of trial NCT01868230?

This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2014-06. Estimated completion is 2020-07.

What conditions does trial NCT01868230 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01868230?

The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01868230?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01868230 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.